RFI

MENU

Szukaj
Doctor discussing with a patient while the patient reads the Package Leaflet, highlighting the importance of Product Information (PI) in the pre-authorisation stage of medicinal products. The PI includes essential details such as dosage, contraindications, and potential side effects, ensuring patient safety and effective communication. Key components like the Summary of Product Characteristics (SmPC) and labelling are crucial for healthcare professionals and patients.

Preparation of product information

The Importance of Product Information in Medicinal Product Pre-Authorisation

Preparation of product information is a crucial step in the pre-authorisation stage of a medicinal product. Product Information (PI) consists of essential documents that provide officially approved and accurate information for healthcare professionals, such as doctors, nurses, and pharmacists, as well as for patients. These documents include critical details such as dosage, contraindications, and potential side effects of the medicine. The core components of the PI are the Summary of Product Characteristics (SmPC), Package Leaflet (PL), and labelling. These documents play a vital role in ensuring patient safety and effective communication of product information.

A pharmacist discussing with a patient in a pharmacy, emphasizing the importance of accurate and clear product information (PI) in the pre-authorization stage of medicinal products. The discussion covers key aspects like dosage, contraindications, and potential side effects, reflecting SciencePharma's commitment to ensuring compliance with European guidelines through well-prepared Summary of Product Characteristics (SmPC), Package Leaflets (PL), and labelling for patient safety and effective communication.

Comprehensive Product Information Services by SciencePharma

At SciencePharma, we are highly attentive to the requirements outlined in the European guidelines regarding the preparation of the Product Information, as well as the graphic designs for leaflets and packaging (Module 1.3.2 CTD). This includes a focus on both immediate and outer packaging. We may support you also in the preparation of this important part of documentation.

Our services include:

  • Preparation of Summary of Product Characteristics (SmPC), Product Leaflet (PL), and immediate & outer labelling. We prepare these documents based on the Quality Review of Documents (QRD) templates.
  • Verification of package leaflet and labelling. We thoroughly review the inner and outer labelling mock-ups for compliance with regulatory requirements, ensuring they adhere to both local and European standards.
  • Conduction of Readability Tests. We conduct these tests and prepare all necessary documentation, including protocols, questionnaires, and reports, to ensure the leaflets are understandable to patients.
  • Writing of Bridging Reports. We develop comprehensive Bridging Reports that justify the rationale for bridging, provided in a format ready for submission.
  • Translation Services. We offer professional Polish/English and English/Polish translations of the PI for registration and post-authorisation procedures.
  • Educational Materials Verification. We also verify educational materials, including Risk Management Measures (RMM), to ensure compliance and clarity.

Our extensive experience in regulatory affairs and product information preparation allows us to support companies in navigating the complex requirements of medicinal product authorisation.

How can we help You?